Bellevue Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $59.3K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $168K | Hold |
|
|||||
|
2024
Q3 | $222K | Hold |
|
|||||
|
2024
Q2 | $164K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.85M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Buy |
|
|||||
|
2021
Q4 | $1.77M | Sell |
|
|||||
|
2021
Q3 | $2.52M | Buy |
|
|||||
|
2021
Q2 | $2.04M | Sell |
|
|||||
|
2021
Q1 | $4.67M | Hold |
|
|||||
|
2020
Q4 | $5.68M | Hold |
|
|||||
|
2020
Q3 | $3.37M | Buy |
|
|||||
|
2020
Q2 | $1.88M | Buy |
|
|||||
|
2020
Q1 | $955K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.45M | Sell |
|
|||||
|
2019
Q1 | $2.07M | Buy |
|
|||||
|
2018
Q4 | $965K | Sell |
|
|||||
|
2018
Q3 | $2.43M | Sell |
|
|||||
|
2018
Q2 | $3.01M | Sell |
|
|||||
|
2018
Q1 | $2.06M | Sell |
|
|||||
|
2017
Q4 | $1.9M | Sell |
|
|||||
|
2017
Q3 | $2.24M | Hold |
|
|||||
|
2017
Q2 | $1.61M | Hold |
|
|||||
|
2017
Q1 | $2.85M | Sell |
|
|||||
|
2016
Q4 | $3.02M | Hold |
|
|||||
|
2016
Q3 | $3.05M | Buy |
|
|||||
|
2016
Q2 | $1.37M | Buy |
|
|||||
|
2016
Q1 | $633K | Buy |
|